Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment...

Ogkologos - 3 Απριλίου, 2025

Plasma-Based, Tumour-Informed MRD Analysis May Predict Recurrence During Adjuvant Osimertinib and...

Ogkologos - 2 Απριλίου, 2025

Talquetamab Continues To Demonstrate High Overall Response Rates in Heavily Pretreated...

Ogkologos - 1 Απριλίου, 2025

Talquetamab Continuous To Demonstrate High Overall Response Rates in Heavily Pretreated...

Ogkologos - 1 Απριλίου, 2025

Suggesting a Deadline in the Invitation Letter to FIT Colorectal Cancer...

Ogkologos - 31 Μαρτίου, 2025

EMA Recommends Extension of Indications for Durvalumab to Include Treatment of...

Ogkologos - 28 Μαρτίου, 2025

Experimental Treatment Uses Engineered Fat Cells to “Starve” Tumors

Ogkologos - 27 Μαρτίου, 2025

FDA Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or...

Ogkologos - 27 Μαρτίου, 2025

Zenocutuzumab Approved to Treat Lung and Pancreatic Cancers with Rare Genetic...

Ogkologos - 26 Μαρτίου, 2025

Distinct and Overlapping Pathways Contribute to the Efficacy of Nivolumab-Based Regimens...

Ogkologos - 26 Μαρτίου, 2025

1...535455...440 Σελίδα 54 από 440

MOST POPULAR

Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases

26 Αυγούστου, 2019

How we are working with industry to translate research into real...

26 Απριλίου, 2022

EMA Reminds Physicians to Use Atezolizumab with Nab-paclitaxel for Treating TNBC

6 Οκτωβρίου, 2020

Hormone Therapy Has A Stronger Impact On A Woman’s Quality Of...

16 Οκτωβρίου, 2019

Φόρτωση περισσοτέρων

EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment...

Plasma-Based, Tumour-Informed MRD Analysis May Predict Recurrence During Adjuvant Osimertinib and...

Talquetamab Continues To Demonstrate High Overall Response Rates in Heavily Pretreated...

Talquetamab Continuous To Demonstrate High Overall Response Rates in Heavily Pretreated...

Suggesting a Deadline in the Invitation Letter to FIT Colorectal Cancer...

EMA Recommends Extension of Indications for Durvalumab to Include Treatment of...

Experimental Treatment Uses Engineered Fat Cells to “Starve” Tumors

FDA Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or...

Zenocutuzumab Approved to Treat Lung and Pancreatic Cancers with Rare Genetic...

Distinct and Overlapping Pathways Contribute to the Efficacy of Nivolumab-Based Regimens...

MOST POPULAR

Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases

How we are working with industry to translate research into real...

EMA Reminds Physicians to Use Atezolizumab with Nab-paclitaxel for Treating TNBC

Hormone Therapy Has A Stronger Impact On A Woman’s Quality Of...

HOT NEWS

ESMO Welcomes European Parliament (EP) report on Psychosocial Risks (PSR) at...

Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in...

Pivotal Role of the Institutional Molecular Tumour Board in Evaluating the...

NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ